A promising new way to transplant cells could lead to a better treatment for Type 1 diabetes (opens in new tab)

Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a novel device to transplant insulin-producing cells that integrates directly with existing blood vessels in the body. The technology, which showed promising results in preclinical trials, aims to overcome key challenges of emerging long-term cell-based treatments for Type 1 diabetes. As well as serving as an artificial pancreas, it potentially could be used to replace o...